New Principal Hire Expands Exponent's Digital Health Team

Digital health expert Ariel Dowling, Ph.D., joins Exponent's Biomechanics Practice in our Natick office

With more than 15 years of experience with wearable technology, medical devices, and digital health solutions, Ariel Dowling, Ph.D., brings extensive expertise in supporting their assessment, evaluation, implementation, and overarching regulatory compliance to Exponent's robust digital health capabilities. Most recently, as senior director for a major pharmaceutical company, Dr. Dowling developed digital device strategies for clinical programs across multiple therapeutic areas and oversaw verification and validation testing of novel, cutting-edge digital health technologies (DHTs) against gold standards for use in clinical investigations.

"I am excited to join Exponent, a company known for innovative scientific consulting with expertise in many aspects of digital health, including data science, biomedical engineering, health sciences, human factors, and real-world evidence," said Dr. Dowling. "I look forward to working across disciplines to leverage digital health technology to improve health outcomes." 

Exponent's multidisciplinary digital health experts are well versed in the assessment and characterization of state-of-the art and rapidly evolving DHTs using innovative, real-world approaches that inherently consider use-case requirements, therapeutic applications, and patient populations. These approaches, supported by our state-of-the-art biomechanics labs and research facilities and extensive data science capabilities, help clients design, develop, and identify fit-for-purpose DHTs that provide high-quality and actionable data, while simultaneously enhancing the patient experience and associated health outcomes. Additionally, we help clients develop a digital endpoint strategy that includes regulatory submission requirements, reimbursement pathways, and DHT integration into the clinical workflow.

Dr. Dowling is one of the founding members of the Digital Medicine Society (DiMe), a global nonprofit driving the adoption of digital approaches to advance medicine and improve public health. Dr. Dowling is also a co-author and technical expert of the V3 framework (verification, analytical validation, and clinical validation), which is the primary international resource for evaluating DHTs to determine fit-for-purpose applications in clinical use cases throughout the healthcare value chain.

"We are so excited for Ariel to join Exponent as we continue to build our digital health capabilities and support existing and new clients in this exciting area," said Principal Scientist Scott McLean, Ph.D. "Ariel will immediately complement our strong multidisciplinary team of biomechanists, data scientists, and health scientists who are already working in this area, helping us to innovatively meet evolving client needs and ensuring high-quality, high-value outcomes."